Pamela J Hodul

Summary

Affiliation: H. Lee Moffitt Cancer Center and Research Institute
Country: USA

Publications

  1. ncbi request reprint Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?
    Pamela J Hodul
    Gastrointestinal Tumor Program, Departmentsof Surgery, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 15:314-21. 2008
  2. doi request reprint Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications
    Jonathan R Strosberg
    Department of GI Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    Ann Surg 256:321-5. 2012
  3. doi request reprint Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer
    Jong Y Park
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Pancreas 36:e32-9. 2008
  4. doi request reprint Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated
    Michael D Chuong
    Department of Radiation Oncology, H Lee Moffitt Cancer Center, Tampa, FL 33612, USA
    Int J Radiat Oncol Biol Phys 86:516-22. 2013
  5. pmc Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism
    Pamela J Hodul
    Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America
    PLoS ONE 8:e52526. 2013
  6. ncbi request reprint Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution
    James F Helm
    Gastrointestinal Tumor Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 15:288-94. 2008
  7. ncbi request reprint Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy
    Sean P Barnett
    Department of Surgery and Biostatistics, Loyola Stritch School of Medicine, Maywood, Illinois, USA
    Am Surg 70:222-6; discussion 227. 2004
  8. ncbi request reprint Zero mortality after 152 consecutive pancreaticoduodenectomies with pancreaticogastrostomy
    Gerard V Aranha
    Section of Surgical Oncology, Hines VA Hospital, Maywood, IL 60153, USA
    J Am Coll Surg 197:223-31; discussion 231-2. 2003

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?
    Pamela J Hodul
    Gastrointestinal Tumor Program, Departmentsof Surgery, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 15:314-21. 2008
    ..This paper discusses whether aggressive surgical intervention is indicated for PNETs and investigates what prognostic factors may assist in predicting which patients with invasive disease will benefit most from surgical intervention...
  2. doi request reprint Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications
    Jonathan R Strosberg
    Department of GI Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    Ann Surg 256:321-5. 2012
    ....
  3. doi request reprint Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer
    Jong Y Park
    Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Pancreas 36:e32-9. 2008
    ....
  4. doi request reprint Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated
    Michael D Chuong
    Department of Radiation Oncology, H Lee Moffitt Cancer Center, Tampa, FL 33612, USA
    Int J Radiat Oncol Biol Phys 86:516-22. 2013
    ....
  5. pmc Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism
    Pamela J Hodul
    Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America
    PLoS ONE 8:e52526. 2013
    ....
  6. ncbi request reprint Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution
    James F Helm
    Gastrointestinal Tumor Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 15:288-94. 2008
    ....
  7. ncbi request reprint Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy
    Sean P Barnett
    Department of Surgery and Biostatistics, Loyola Stritch School of Medicine, Maywood, Illinois, USA
    Am Surg 70:222-6; discussion 227. 2004
    ..026). Octreotide did not reduce pancreatic fistula, other complications, or mortality. Octreotide may contribute cardiac morbidity. Octreotide cannot be recommended to prevent mortality or postoperative complications after PD...
  8. ncbi request reprint Zero mortality after 152 consecutive pancreaticoduodenectomies with pancreaticogastrostomy
    Gerard V Aranha
    Section of Surgical Oncology, Hines VA Hospital, Maywood, IL 60153, USA
    J Am Coll Surg 197:223-31; discussion 231-2. 2003
    ..In all of these series, the pancreatic remnant was anastomosed to the jejunum...